Related Experiment Video
Updated: Aug 29, 2026

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
Published on: September 11, 2019
Psychomotor slowing in hepatitis C and HIV infection
Hans-Jürgen von Giesen1, Tobias Heintges, Naghme Abbasi-Boroudjeni
1Department of Neurology, Hepatology and Infectious Diseases, Heinrich Heine University, Düsseldorf, Germany. giesenhj@uni-duesseldorf.de
Insights
Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) can affect cognitive and motor functions. This study found psychomotor slowing in both HIV and HCV patients, with prolonged reaction times specifically in coinfected individuals.
Area of Science:
- Neuroscience
- Infectious Diseases
- Neurology
Background:
- Both Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) can impact the central nervous system, potentially causing cognitive and motor deficits.
- Limited data exists on cognitive function and virtually no data on motor performance in patients coinfected with HIV and HCV.
Purpose of the Study:
- To assess and compare cognitive and motor performance in patients with HIV/HCV coinfection.
- To provide data on the neurological impact of HIV and HCV infections, individually and combined.
Main Methods:
- Compared three groups: HIV-seropositive/HCV-seronegative (n=43), HIV/HCV-coinfected (n=43), and HIV-negative/HCV-positive (n=44).
- Utilized neuropsychological testing and electrophysiological assessments of basal ganglia-mediated motor function.
Main Results:
- No significant differences were observed in intelligence, attention, memory, HIV dementia scale, or most somatic/psychiatric complaints across groups.
- HIV-negative/HCV-positive patients reported fewer affective disorders and lower depression scores.
- All three groups exhibited pathological slowing of rapid alternating movements and prolonged contraction times; only HIV/HCV-coinfected patients showed significantly prolonged simple reaction times.
Conclusions:
- Clinically asymptomatic HIV-positive and HCV-positive patients may exhibit affective disturbances and significant psychomotor slowing.
- The predictive value of these findings for disease progression requires further investigation, particularly in HCV-positive and coinfected individuals.
Background:
Both HIV and hepatitis C virus (HCV) may enter the central nervous system and cause cognitive and/or motor dysfunction. There are limited data on cognition and no data on motor performance in HIV/HCV-coinfected patients.
Objective:
To provide data on cognition and motor performance in HIV/HCV infected patients.
Methods:
We compared 43 HIV-seropositive but HCV-seronegative patients, 43 HIV/HCV-coinfected patients, and 44 HIV-negative but HCV-positive patients, all of whom went through neuropsychologic testing and electrophysiologic assessment of basal ganglia-mediated motor function.
Results:
No significant differences could be found among the groups with regard to premorbid verbal and actual nonverbal intelligence, attention, and memory; the HIV dementia scale; and all somatic and most psychiatric complaints. Affective disorders were less frequent in HIV-negative but HCV-positive patients. This group also scored lower for depression. For all 3 groups, significant pathologic slowing of most rapid alternating movements (right hand) compared with those of HIV/HCV-negative controls as well as significantly prolonged contraction times (both hands) could be diagnosed. Simple reaction times were significantly prolonged only in HIV/HCV-coinfected patients.
Conclusions:
Although clinically asymptomatic, both HIV-positive and HCV-positive patients may show affective disturbances and significant psychomotor slowing. A potential predictive value for the further course of infection, which is well established in HIV-positive patients, remains to be investigated in HCV-positive or HIV/HCV-coinfected patients.
More Related Videos
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatitis
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Hepatic Encephalopathy
Viral Hepatitis I: Introduction
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

